[HTML][HTML] A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients …
FA Bethoux, R Farrell, D Checketts, N Sahr… - Multiple Sclerosis and …, 2024 - Elsevier
Background Spasticity is a common and potentially debilitating symptom of multiple
sclerosis (MS) with a highly variable presentation. Understanding, quantifying, and …
sclerosis (MS) with a highly variable presentation. Understanding, quantifying, and …
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With …
FA Bethoux, R Farrell, D Checketts, N Sahr… - Multiple Sclerosis and … - msard-journal.com
Background Spasticity is a common and potentially debilitating symptom of multiple
sclerosis (MS) with a highly variable presentation. Understanding, quantifying, and …
sclerosis (MS) with a highly variable presentation. Understanding, quantifying, and …